文献速递脑血管病

大缺血性卒中患者血管内治疗与药物治疗的时间-疗效关联

Association Between Time to Treatment and Outcomes of Endovascular Therapy vs Medical Management in Patients With Large Ischemic Stroke.
PubMed 文献 · Neurology · 2024-12-09

本研究为TENSION随机试验的事后分析,纳入451例大缺血性卒中患者,比较血管内治疗(EVT)联合药物治疗与单纯药物治疗在不同发病至预期动脉穿刺时间(OPT)下的疗效。结果显示OPT<6小时(44.4% vs 29.9%,aOR 2.78)和6-12小时(45.7% vs 29.6%,aOR 2.39)EVT组良好预后率更高,超过12小时无显著差异;获益在OPT超过13小时22分钟后变得不显著。

要点

  • OPT<6小时EVT组良好预后率44.4% vs 药物治疗组29.9%(aOR 2.78,95%CI 1.22-6.32)。
  • OPT 6-12小时EVT组良好预后率45.7% vs 药物治疗组29.6%(aOR 2.39,95%CI 1.21-4.71)。
  • OPT>12小时两组良好预后率无显著差异(51.6% vs 41.4%,aOR 2.05,95%CI 0.88-4.77)。

核心结论

  • 大缺血性卒中患者发病13小时22分钟内启动EVT较单纯药物治疗获益更明显,但超过13小时22分钟不应放弃EVT。
  • 需要更大样本的汇总分析。

研究设计与样本

  • TENSION随机试验的事后分析,纳入451例前循环大血管闭塞伴大面积梗死核心患者。
  • 患者接受EVT联合药物治疗或单纯药物治疗。
  • 按发病至预期动脉穿刺时间(OPT)分为<6、6-<12、12-24小时三组进行分析。

主要发现

  • OPT<6小时:EVT组良好预后率44.4% vs 药物治疗组29.9%(aOR 2.78,95%CI 1.22-6.32)。
  • OPT 6-12小时:EVT组良好预后率45.7% vs 药物治疗组29.6%(aOR 2.39,95%CI 1.21-4.71)。
  • OPT>12小时:EVT组良好预后率51.6% vs 药物治疗组41.4%(aOR 2.05,95%CI 0.88-4.77),差异无统计学显著性。
  • 获益在OPT超过13小时22分钟后变得不显著。
  • 三个OPT区间内症状性颅内出血和死亡率两组相似,任何颅内出血率增加,但无交互效应(所有交互p>0.10)。

临床怎么用

  • 作者认为,大缺血性卒中患者发病13小时22分钟内启动EVT较单纯药物治疗获益更明显。
  • 作者认为,超过13小时22分钟就诊的患者不应放弃EVT。

局限性

  • 需要更大样本量的汇总分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Randomized trials have proven the benefit of endovascular therapy (EVT) for acute large ischemic stroke. This study was to characterize the effect of time to treatment on benefit of EVT vs medical management (MM) among patients with large ischemic stroke. METHODS: This was a post hoc analysis of the Endovascular Therapy in Acute Anterior Circulation Large Vessel Occlusive Patients with a Large Infarct Core randomized trial. Patients who had an Alberta Stroke Program Early Computed Tomography Score of 3-5 or an ischemic core volume of 70-100 mL within 24 hours of symptom onset were treated with EVT plus MM or MM. Onset-to-expected arterial puncture time (OPT) was analyzed as a categorical variable (<6, 6-<12, and 12-24 hours) using binary logistic regression and as a continuous variable using a multivariable fractional polynomial interaction. The primary efficacy outcome was favorable outcomes (modified Rankin Scale scores 0-3) at 90 days. Safety outcomes included any intracranial hemorrhage (ICH), symptomatic ICH, and mortality. RESULTS: Among 451 patients (median age 68 years; 61.4% were men; median OPT 487 minutes [interquartile range 328-802]), 226 patients received EVT and 225 patients received MM. The EVT group showed higher rates of favorable outcomes than the MM group within OPT of 6 hours (44.4% vs 29.9%, adjusted odds ratio [aOR] 2.78, 95% CI 1.22-6.32) and 6-12 hours (45.7% vs 29.6%, aOR 2.39 [95% CI 1.21-4.71]), but not in OPT beyond 12 hours (51.6% vs 41.4%, aOR 2.05 [95% CI 0.88-4.77]). The benefit became nonsignificant after OPT of 13 hours and 22 minutes. In 3 OPT intervals, the rates of symptomatic ICH and mortality were similar between EVT and MM although the rate of any ICH increased. However, no interaction effect was found (all p interactions >0.10). DISCUSSION: These findings strengthen the benefit of EVT initiated within 13 hours and 22 minutes after symptom onset compared with MM alone in patients with large ischemic stroke, but EVT should not be withheld for patients presenting beyond 13 hours and 22 minutes. Pooled analysis of larger sample sizes is needed. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov; NCT04551664. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that EVT is associated with improved functional outcomes for acute large ischemic stroke within 24 hours after last known well, with no interaction by time.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Yuan G, Sang H, Nguyen TN, et al. Association Between Time to Treatment and Outcomes of Endovascular Therapy vs Medical Management in Patients With Large Ischemic Stroke. Neurology. 2024. PMID: 39652807. doi:10.1212/WNL.0000000000210133

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。